Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posterior versus anterior axillary nerve block approaches with liposomal bupivacaine after arthroscopic shoulder surgery
ChiCTR2400088253Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine in Rotator cuff deficiency (RCD) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Area under the curve of rest pain intensity scores through 72 hours postsurgery. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2400088253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088253.